James W. McCollum

CIK: 0001200889

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LENZ

LENZ Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

LENZ
LENZ Therapeutics, Inc.
Jun 15, 2026
Award(A)
Stock Option (right to buy)
Direct
22.1K shares-
LENZ
LENZ Therapeutics, Inc.
Nov 7, 2025
Purchase(P)
Direct
10.5K shares at avg. $22.79$239K
LENZ
LENZ Therapeutics, Inc.
Jun 11, 2025
Award(A)
Stock Option (right to buy)
Direct
13.5K shares-

		Type	Shares	Price		Ownership
Jun 15, 2026	LENZ LENZ Therapeutics, Inc.	Award(A) Stock Option (right to buy)	22,100	-	-	Direct
Nov 7, 2025	LENZ LENZ Therapeutics, Inc.	Purchase(P)	10,500	$22.79	$239,278	Direct
Jun 11, 2025	LENZ LENZ Therapeutics, Inc.	Award(A) Stock Option (right to buy)	13,500	-	-	Direct

1-3 of 3 transactions

About MCCOLLUM JAMES W

MCCOLLUM JAMES W (SEC CIK 0001200889) files insider reports with the SEC as Director of LENZ Therapeutics, Inc. (LENZ).

Signal8 holds 3 ownership filings by MCCOLLUM JAMES W, all Form 4s, filed between Jun 11, 2025 and Jun 15, 2026. Those filings report 3 transactions, from Jun 11, 2025 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MCCOLLUM JAMES W's filings is in SOLANA BEACH, CA.

Recent filings by MCCOLLUM JAMES W

Jun 15, 2026: Grant or award of LENZ derivative securities (Form 4, code A).
Nov 7, 2025: Open-market purchase of LENZ shares (Form 4, code P).
Jun 11, 2025: Grant or award of LENZ derivative securities (Form 4, code A).

Other insiders filing for LENZ Therapeutics, Inc. (LENZ)

How to read Form 4 transaction codes